{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:16:43Z","timestamp":1767993403699,"version":"3.49.0"},"reference-count":27,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005189","name":"Estonian Research Competency Council","doi-asserted-by":"publisher","award":["MOBTT39"],"award-info":[{"award-number":["MOBTT39"]}],"id":[{"id":"10.13039\/501100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017M3A9G6068246"],"award-info":[{"award-number":["NRF-2017M3A9G6068246"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Combination therapies have become a standard for the treatment for HIV and hepatitis C virus (HCV) infections. They are advantageous over monotherapies due to better efficacy, reduced toxicity, as well as the ability to prevent the development of resistant viral strains and to treat viral co-infections. Here, we identify new synergistic combinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), echovirus 1 (EV1), hepatitis C virus (HCV) and human immunodeficiency virus 1 (HIV-1) in vitro. We observed synergistic activity of nelfinavir with convalescent serum and with purified neutralizing antibody 23G7 against SARS-CoV-2 in human lung epithelial Calu-3 cells. We also demonstrated synergistic activity of nelfinavir with EIDD-2801 or remdesivir in Calu-3 cells. In addition, we showed synergistic activity of vemurafenib with emetine, homoharringtonine, anisomycin, or cycloheximide against EV1 infection in human lung epithelial A549 cells. We also found that combinations of sofosbuvir with brequinar or niclosamide are synergistic against HCV infection in hepatocyte-derived Huh-7.5 cells, and that combinations of monensin with lamivudine or tenofovir are synergistic against HIV-1 infection in human cervical TZM-bl cells. These results indicate that synergy is achieved when a virus-directed antiviral is combined with another virus- or host-directed agent. Finally, we present an online resource that summarizes novel and known antiviral drug combinations and their developmental status.<\/jats:p>","DOI":"10.3390\/v12101178","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T21:26:06Z","timestamp":1603056366000},"page":"1178","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Identification and Tracking of Antiviral Drug Combinations"],"prefix":"10.3390","volume":"12","author":[{"given":"Aleksandr","family":"Ianevski","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rouan","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Biza","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Zusinaite","sequence":"additional","affiliation":[{"name":"Institute of Technology, University of Tartu, 50090 Tartu, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Mannik","sequence":"additional","affiliation":[{"name":"Icosagen Cell Factory O\u00dc, 61713 Kambja vald Tartumaa, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaily","family":"Kivi","sequence":"additional","affiliation":[{"name":"Icosagen Cell Factory O\u00dc, 61713 Kambja vald Tartumaa, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Planken","sequence":"additional","affiliation":[{"name":"Icosagen Cell Factory O\u00dc, 61713 Kambja vald Tartumaa, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristiina","family":"Kurg","sequence":"additional","affiliation":[{"name":"Icosagen Cell Factory O\u00dc, 61713 Kambja vald Tartumaa, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Maria","family":"Tombak","sequence":"additional","affiliation":[{"name":"Icosagen Cell Factory O\u00dc, 61713 Kambja vald Tartumaa, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Mart","family":"Ustav","sequence":"additional","affiliation":[{"name":"Icosagen Cell Factory O\u00dc, 61713 Kambja vald Tartumaa, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nastassia","family":"Shtaida","sequence":"additional","affiliation":[{"name":"Institute of Technology, University of Tartu, 50090 Tartu, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeny","family":"Kulesskiy","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, FIMM, University of Helsinki, 00014 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunji","family":"Jo","sequence":"additional","affiliation":[{"name":"Applied Molecular Virology Laboratory, Institut Pasteur Korea, Sampyeong-dong 696, Bundang-gu, Seongnam-si 463-400, Gyeonggi-do, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaewon","family":"Yang","sequence":"additional","affiliation":[{"name":"Applied Molecular Virology Laboratory, Institut Pasteur Korea, Sampyeong-dong 696, Bundang-gu, Seongnam-si 463-400, Gyeonggi-do, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Lysvand","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsti","family":"L\u00f8seth","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5088-3791","authenticated-orcid":false,"given":"Valentyn","family":"Oksenych","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Arne","family":"Aas","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-3601","authenticated-orcid":false,"given":"Tanel","family":"Tenson","sequence":"additional","affiliation":[{"name":"Institute of Technology, University of Tartu, 50090 Tartu, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astra","family":"Vitkauskien\u0117","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Lithuanian University of Health Science, 44307 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc P.","family":"Windisch","sequence":"additional","affiliation":[{"name":"Applied Molecular Virology Laboratory, Institut Pasteur Korea, Sampyeong-dong 696, Bundang-gu, Seongnam-si 463-400, Gyeonggi-do, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9102-8409","authenticated-orcid":false,"given":"Mona H\u00f8ys\u00e6ter","family":"Fenstad","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"},{"name":"Department of Medical Microbiology, St. Olavs Hospital, 7006 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svein Arne","family":"Nordb\u00f8","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"},{"name":"Department of Immunology and Transfusion Medicine, St. Olavs Hospital, 7006 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart","family":"Ustav","sequence":"additional","affiliation":[{"name":"Icosagen Cell Factory O\u00dc, 61713 Kambja vald Tartumaa, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8759-1170","authenticated-orcid":false,"given":"Magnar","family":"Bj\u00f8r\u00e5s","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7716-6955","authenticated-orcid":false,"given":"Denis E.","family":"Kainov","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway"},{"name":"Institute of Technology, University of Tartu, 50090 Tartu, Estonia"},{"name":"Institute for Molecular Medicine Finland, FIMM, University of Helsinki, 00014 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"DALYs","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Disease","year":"2017","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","article-title":"Innovation and trends in the development and approval of antiviral medicines: 1987\u20132017 and beyond","volume":"155","author":"Chaudhuri","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijid.2020.02.018","article-title":"Discovery and development of safe-in-man broad-spectrum antiviral agents","volume":"93","author":"Andersen","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2016.07.008","article-title":"JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses","volume":"133","author":"Fu","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2016.12.022","article-title":"Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism","volume":"139","author":"Kuivanen","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ianevski, A., Yao, R., Fenstad, M.H., Biza, S., Zusinaite, E., Reisberg, T., Lysvand, H., Loseth, K., Landsem, V.M., and Malmring, J.F. (2020). Potential Antiviral Options against SARS-CoV-2 Infection. Viruses, 12.","DOI":"10.1101\/2020.05.12.091165"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.antiviral.2016.07.002","article-title":"Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner","volume":"132","author":"Lee","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.meegid.2013.02.011","article-title":"Molecular evolution and epidemiology of echovirus 6 in Finland","volume":"16","author":"Smura","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44676","DOI":"10.1038\/srep44676","article-title":"A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bosl, K., Ianevski, A., Than, T.T., Andersen, P.I., Kuivanen, S., Teppor, M., Zusinaite, E., Dumpis, U., Vitkauskiene, A., and Cox, R.J. (2019). Common Nodes of Virus\u2013Host Interaction Revealed Through an Integrated Network Analysis. Front. Immunol., accepted.","DOI":"10.1101\/548909"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2018.04.016","article-title":"Novel activities of safe-in-human broad-spectrum antiviral agents","volume":"154","author":"Ianevski","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bulanova, D., Ianevski, A., Bugai, A., Akimov, Y., Kuivanen, S., Paavilainen, H., Kakkola, L., Nandania, J., Turunen, L., and Ohman, T. (2017). Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins. Viruses, 9.","DOI":"10.3390\/v9100271"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","article-title":"SynergyFinder: A web application for analyzing drug combination dose-response matrix data","volume":"33","author":"Ianevski","year":"2017","journal-title":"Bioinformatics"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ianevski, A., Giri, A.K., and Aittokallio, T. (2020). SynergyFinder 2.0: Visual analytics of multi-drug combination synergies. Nucleic Acids Res.","DOI":"10.1093\/nar\/gkaa216"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1093\/bioinformatics\/btaa138","article-title":"Breeze: An integrated quality control and data analysis application for high-throughput drug screening","volume":"36","author":"Potdar","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Andersen, P.I., Krpina, K., Ianevski, A., Shtaida, N., Jo, E., Yang, J., Koit, S., Tenson, T., Hukkanen, V., and Anthonsen, M.W. (2019). Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine. Viruses, 11.","DOI":"10.20944\/preprints201909.0128.v1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.drudis.2019.04.006","article-title":"Expanding the activity spectrum of antiviral agents","volume":"24","author":"Ianevski","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1172\/JCI140200","article-title":"Early safety indicators of COVID-19 convalescent plasma in 5000 patients","volume":"130","author":"Joyner","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kivi, G., Teesalu, K., Parik, J., Kontkar, E., Ustav, M., Noodla, L., Ustav, M., and Mannik, A. (2016). HybriFree: A robust and rapid method for the development of monoclonal antibodies from different host species. BMC Biotechnol., 16.","DOI":"10.1186\/s12896-016-0232-6"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","article-title":"Proteomics of SARS-CoV-2-infected host cells reveals therapy targets","volume":"583","author":"Bojkova","year":"2020","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sheahan, T.P., Sims, A.C., Zhou, S., Graham, R.L., Pruijssers, A.J., Agostini, M.L., Leist, S.R., Schafer, A., Dinnon, K.H., and Stevens, L.J. (2020). An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci. Transl. Med., 12.","DOI":"10.1126\/scitranslmed.abb5883"},{"key":"ref_24","first-page":"493","article-title":"Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro","volume":"118","author":"Zhang","year":"2005","journal-title":"Chin. Med. J. (Engl.)"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fonc.2018.00526","article-title":"BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas","volume":"8","author":"Ceglie","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Toots, M., Yoon, J.J., Cox, R.M., Hart, M., Sticher, Z.M., Makhsous, N., Plesker, R., Barrena, A.H., Reddy, P.G., and Mitchell, D.G. (2019). Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci. Transl. Med., 11.","DOI":"10.1126\/scitranslmed.aax5866"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lamb, Y.N. (2020). Remdesivir: First Approval. Drugs.","DOI":"10.1007\/s40265-020-01378-w"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/10\/1178\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:23:26Z","timestamp":1760178206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/10\/1178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,18]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["v12101178"],"URL":"https:\/\/doi.org\/10.3390\/v12101178","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,18]]}}}